LY-3207447

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLY-3207447
Drug Alias NameLY-3207447
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsAngiopoietin-2 inhibitors
TargetsVascular endothelial growth factor receptor 2Angiopoietin-2
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesEli Lilly And Company
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A